{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:34:39Z","timestamp":1777102479899,"version":"3.51.4"},"reference-count":44,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"US Food and Drug Administration","award":["75F40119D10037"],"award-info":[{"award-number":["75F40119D10037"]}]},{"name":"US Food and Drug Administration","award":["75F40119F19001"],"award-info":[{"award-number":["75F40119F19001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["bmjmed"],"accepted":{"date-parts":[[2023,5,3]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To measure the 90 day risk of arterial thromboembolism and venous thromboembolism among patients diagnosed with covid-19 in the ambulatory (ie, outpatient, emergency department, or institutional) setting during periods before and during covid-19 vaccine availability and compare results to patients with ambulatory diagnosed influenza.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Retrospective cohort study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Four integrated health systems and two national health insurers in the US Food and Drug Administration's Sentinel System.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Patients with ambulatory diagnosed covid-19 when vaccines were unavailable in the US (period 1, 1 April-30 November 2020; n=272\u2009065) and when vaccines were available in the US (period 2, 1 December 2020-31 May 2021; n=342\u2009103), and patients with ambulatory diagnosed influenza (1 October 2018-30 April 2019; n=118\u2009618).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Arterial thromboembolism (hospital diagnosis of acute myocardial infarction or ischemic stroke) and venous thromboembolism (hospital diagnosis of acute deep venous thrombosis or pulmonary embolism) within 90 days after ambulatory covid-19 or influenza diagnosis. We developed propensity scores to account for differences between the cohorts and used weighted Cox regression to estimate adjusted hazard ratios of outcomes with 95% confidence intervals for covid-19 during periods 1 and 2 versus influenza.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>90 day absolute risk of arterial thromboembolism with covid-19 was 1.01% (95% confidence interval 0.97% to 1.05%) during period 1, 1.06% (1.03% to 1.10%) during period 2, and with influenza was 0.45% (0.41% to 0.49%). The risk of arterial thromboembolism was higher for patients with covid-19 during period 1 (adjusted hazard ratio 1.53 (95% confidence interval 1.38 to 1.69)) and period 2 (1.69 (1.53 to 1.86)) than for patients with influenza. 90 day absolute risk of venous thromboembolism with covid-19 was 0.73% (0.70% to 0.77%) during period 1, 0.88% (0.84 to 0.91%) during period 2, and with influenza was 0.18% (0.16% to 0.21%). Risk of venous thromboembolism was higher with covid-19 during period 1 (adjusted hazard ratio 2.86 (2.46 to 3.32)) and period 2 (3.56 (3.08 to 4.12)) than with influenza.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients diagnosed with covid-19 in the ambulatory setting had a higher 90 day risk of admission to hospital with arterial thromboembolism and venous thromboembolism both before and after covid-19 vaccine availability compared with patients with influenza.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjmed-2022-000421","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T03:53:47Z","timestamp":1686110027000},"page":"e000421","source":"Crossref","is-referenced-by-count":6,"title":["Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort study"],"prefix":"10.1136","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0600","authenticated-orcid":false,"suffix":"III","given":"Vincent","family":"Lo Re","sequence":"first","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"},{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-2890","authenticated-orcid":false,"given":"Sarah K","family":"Dutcher","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-557X","authenticated-orcid":false,"given":"John G","family":"Connolly","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-1502","authenticated-orcid":false,"given":"Silvia","family":"Perez-Vilar","sequence":"additional","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0310-270X","authenticated-orcid":false,"given":"Dean M","family":"Carbonari","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terese A","family":"DeFor","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Bloomington, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-0691","authenticated-orcid":false,"given":"Djeneba Audrey","family":"Djibo","sequence":"additional","affiliation":[{"name":"CVS Health Clinical Trial Services, an affiliate of Aetna, CVS Health Company, Blue Bell, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5951-8291","authenticated-orcid":false,"given":"Laura B","family":"Harrington","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Washington Health Research Institute and Department of Epidemiology, University of Washington, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-2574","authenticated-orcid":false,"given":"Laura","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4726-9413","authenticated-orcid":false,"given":"Sean","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-0994","authenticated-orcid":false,"given":"Rebecca A","family":"Hubbard","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E","family":"Kempner","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-6853","authenticated-orcid":false,"given":"Jennifer L","family":"Kuntz","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Northwest Center for Health Research, Portland, OR, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-6527","authenticated-orcid":false,"given":"Cheryl N","family":"McMahill-Walraven","sequence":"additional","affiliation":[{"name":"CVS Health Clinical Trial Services, an affiliate of Aetna, CVS Health Company, Blue Bell, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolene","family":"Mosley","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-5764","authenticated-orcid":false,"given":"Pamala A","family":"Pawloski","sequence":"additional","affiliation":[{"name":"HealthPartners Institute, Bloomington, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-6236","authenticated-orcid":false,"given":"Andrew B","family":"Petrone","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-454X","authenticated-orcid":false,"given":"Allyson M","family":"Pishko","sequence":"additional","affiliation":[{"name":"Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1371-9658","authenticated-orcid":false,"given":"Meighan","family":"Rogers Driscoll","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia A","family":"Steiner","sequence":"additional","affiliation":[{"name":"Kaiser Permanente Colorado Institute for Health Research, Aurora, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Humana Healthcare Research, Inc, Louisville, KY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7090-2761","authenticated-orcid":false,"given":"Noelle M","family":"Cocoros","sequence":"additional","affiliation":[{"name":"Department of Population Medicine, Harvard Medical School, Boston, MA, USA"},{"name":"Department of Population Medicine, Harvard Pilgrim Health Care Inc, Wellesley, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"key":"2025080501005627000_2.1.e000421.1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid antibodies in patients with COVID-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N Engl J Med"},{"key":"2025080501005627000_2.1.e000421.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006520"},{"key":"2025080501005627000_2.1.e000421.3","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"2025080501005627000_2.1.e000421.4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1710018"},{"key":"2025080501005627000_2.1.e000421.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006000"},{"key":"2025080501005627000_2.1.e000421.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13072"},{"key":"2025080501005627000_2.1.e000421.7","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/cid\/ciab003","article-title":"Venous thromboembolism and major bleeding in patients with Coronavirus disease 2019 (COVID-19): a nationwide, population-based cohort study","volume":"73","author":"Dalager-Pedersen","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025080501005627000_2.1.e000421.8","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00223-7"},{"key":"2025080501005627000_2.1.e000421.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702090"},{"key":"2025080501005627000_2.1.e000421.10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/acn3.545","article-title":"Influenza-like illness as a trigger for ischemic stroke","volume":"5","author":"Boehme","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"2025080501005627000_2.1.e000421.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq125"},{"key":"2025080501005627000_2.1.e000421.12","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw214","article-title":"H1N1-induced venous thromboembolic events? Results of a single-institution case series","volume":"3","author":"Dimakakos","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2025080501005627000_2.1.e000421.13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.5240","article-title":"A COVID-19-ready public health surveillance system: The Food and Drug Administration\u2019s sentinel system","volume":"30","author":"Cocoros","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2025080501005627000_2.1.e000421.14","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2336"},{"key":"2025080501005627000_2.1.e000421.15","unstructured":"Sentinel Operations Center . Sentinel data quality assurance practices compliance with \"guidance for industry and FDA staff: best practices for conducting and reporting Pharmacoepidemiology safety studies using electronic Healthcare data\". Available: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/data\/distributed-database\/Sentinel_DataQAPractices_Memo.pdf [Accessed 1 Feb 2023]."},{"key":"2025080501005627000_2.1.e000421.16","unstructured":"Sentinel Operations Center . Data quality review and characterization programs: quality assurance (QA) package. Available: https:\/\/dev.sentinelsystem.org\/projects\/QA\/repos\/qa_package\/browse [Accessed 1 Feb 2023]."},{"key":"2025080501005627000_2.1.e000421.17","unstructured":"Maro JC . Medical product safety surveillance: data quality in the sentinel initiative. Available: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/communications\/publications-presentations\/Sentinel_Canadian-Society-Pharmaceutical-Sciences_Presentation_Medical-Product-Safety-Surveillance-Data-Quality.pdf [Accessed 1 Feb 2023]."},{"key":"2025080501005627000_2.1.e000421.18","unstructured":"Sentinel Operations Center . Study Synopsis: natural history of coagulopathy in COVID-19. Version 2.0. 2021. Available: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/documents\/Coagulopathy_COVID19_Study_Synopsis_v2.0_0.pdf"},{"key":"2025080501005627000_2.1.e000421.19","unstructured":"Rosati K , Jorgensen N , Soliz M , et al . Sentinel initiative principles and policies: HIPAA and common rule compliance in the sentinel initiative. Available: https:\/\/www.sentinelinitiative.org\/sites\/default\/files\/communications\/publications-presentations\/HIPAA-Common-Rule-Compliance-in-Sentinel-Initiative.pdf [Accessed 31 Oct 2021]."},{"key":"2025080501005627000_2.1.e000421.20","unstructured":"Basic HHS policy for protection of human research subjects, 45 CFR \u00a746.102(L)(2). Available: https:\/\/www.ecfr.gov\/current\/title-45\/subtitle-A\/subchapter-A\/part-46\/subpart-A#46.102 [Accessed 2 Nov 2021]."},{"key":"2025080501005627000_2.1.e000421.21","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5401"},{"key":"2025080501005627000_2.1.e000421.22","unstructured":"United States Food and Drug Administration Sentinel Initiative . Master protocol development: COVID-19 natural history. Available: https:\/\/www.sentinelinitiative.org\/sentinel\/methods\/master-protocol-development-covid-19-natural-history [Accessed 27 Oct 2021]."},{"key":"2025080501005627000_2.1.e000421.23","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6824a3"},{"key":"2025080501005627000_2.1.e000421.24","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4398"},{"key":"2025080501005627000_2.1.e000421.25","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3310"},{"key":"2025080501005627000_2.1.e000421.26","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1518"},{"key":"2025080501005627000_2.1.e000421.27","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1924"},{"key":"2025080501005627000_2.1.e000421.28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009960","article-title":"Chart validation of inpatient International classification of diseases, ninth revision, clinical modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the sentinel distributed database","volume":"97","author":"Ammann","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025080501005627000_2.1.e000421.29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2015.09.087","article-title":"Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females","volume":"34","author":"Yih","year":"2016","journal-title":"Vaccine"},{"key":"2025080501005627000_2.1.e000421.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01840-0"},{"key":"2025080501005627000_2.1.e000421.31","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5142"},{"key":"2025080501005627000_2.1.e000421.32","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1136\/bmj.n1416","article-title":"Global COVID-19 vaccine rollout and safety surveillance-how to keep pace","volume":"373","author":"Lo Re","year":"2021","journal-title":"BMJ"},{"key":"2025080501005627000_2.1.e000421.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.330.7497.960"},{"key":"2025080501005627000_2.1.e000421.34","unstructured":"Marubini E , Valsecchi M . Analysing survival data from clinical trials and observational studies. Chichester, England: John Wiley & Sons, 1995: 331\u201364."},{"key":"2025080501005627000_2.1.e000421.35","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000595"},{"key":"2025080501005627000_2.1.e000421.36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l5657","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a Primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ"},{"key":"2025080501005627000_2.1.e000421.37","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1177\/0962280219869742","article-title":"Inverse probability weighted cox model in multi-site studies without sharing individual-level data","volume":"29","author":"Shu","year":"2020","journal-title":"Stat Methods Med Res"},{"key":"2025080501005627000_2.1.e000421.38","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"2025080501005627000_2.1.e000421.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5"},{"key":"2025080501005627000_2.1.e000421.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432"},{"key":"2025080501005627000_2.1.e000421.41","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"2025080501005627000_2.1.e000421.42","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1820"},{"key":"2025080501005627000_2.1.e000421.43","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.21554"},{"key":"2025080501005627000_2.1.e000421.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.10.004"}],"container-title":["BMJ Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjmed-2022-000421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T08:01:06Z","timestamp":1754380866000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjmedicine.bmj.com\/lookup\/doi\/10.1136\/bmjmed-2022-000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,6]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjmed-2022-000421"],"URL":"https:\/\/doi.org\/10.1136\/bmjmed-2022-000421","relation":{},"ISSN":["2754-0413"],"issn-type":[{"value":"2754-0413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}